164 related articles for article (PubMed ID: 17225603)
1. Spectrofluorometric determination of verapamil hydrochloride in pharmaceutical preparations and human plasma using organized media: application to stability studies.
Walash M; Belal F; El-Enany N; Abdelsalam A
J AOAC Int; 2006; 89(6):1565-72. PubMed ID: 17225603
[TBL] [Abstract][Full Text] [Related]
2. Spectrofluorometric determination of citalopram in pharmaceutical preparations and spiked human plasma using organized media.
El-Sherbiny DT
J AOAC Int; 2006; 89(5):1288-95. PubMed ID: 17042177
[TBL] [Abstract][Full Text] [Related]
3. Spectrofluorometric determination of nimodipine in dosage forms and human urine.
Belal F; Al-Majed AA; Julkhuf S; Khalil NY
Pharmazie; 2003 Dec; 58(12):874-6. PubMed ID: 14703964
[TBL] [Abstract][Full Text] [Related]
4. Micellar enhanced spectrofluorometric determination of labetalol through complexation with aluminium(III): application to dosage forms and biological fluids.
El-Enany N
J AOAC Int; 2007; 90(4):948-56. PubMed ID: 17760332
[TBL] [Abstract][Full Text] [Related]
5. Spectrofluorometric determination of olanzapine and fluphenazine hydrochloride in pharmaceutical preparations and human plasma using eosin: application to stability studies.
Belal F; El-Brashy A; El-Enany N; El-Bahay N
J AOAC Int; 2008; 91(6):1309-17. PubMed ID: 19202791
[TBL] [Abstract][Full Text] [Related]
6. Micelle-enhanced spectrofluorimetric method for determination of lacidipine in tablet form; application to content uniformity testing.
Belal F; Sharaf El-Din M; Tolba MM; Alaa H
Luminescence; 2015 Sep; 30(6):805-11. PubMed ID: 25504545
[TBL] [Abstract][Full Text] [Related]
7. Enhanced spectrofluorimetric determination of esomeprazole and pantoprazole in dosage forms and spiked human plasma using organized media.
Belal F; Sharaf El-Din M; Tolba MM; Alaa H
Luminescence; 2015 May; 30(3):343-51. PubMed ID: 25060291
[TBL] [Abstract][Full Text] [Related]
8. An eco-friendly stability-indicating spectrofluorimetric method for the determination of two anticancer stereoisomer drugs in their pharmaceutical preparations following micellar enhancement: Application to kinetic degradation studies.
El-Kimary EI; El-Yazbi AF
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jun; 163():145-53. PubMed ID: 27045788
[TBL] [Abstract][Full Text] [Related]
9. Second-derivative synchronous fluorometric method for the simultaneous determination of cinnarizine and domperidone in pharmaceutical preparations. Application to biological fluids.
Walash MI; Belal F; El-Enany N; Abdelal AA
J Fluoresc; 2008 Jan; 18(1):61-74. PubMed ID: 17899334
[TBL] [Abstract][Full Text] [Related]
10. Spectrofluorometric determination of some beta-blockers in tablets and human plasma using 9,10-dimethoxyanthracene-2-sodium sulfonate.
Abdine H; Sultan MA; Hefnawy MM; Belal F
Pharmazie; 2005 Apr; 60(4):265-8. PubMed ID: 15881605
[TBL] [Abstract][Full Text] [Related]
11. Micelle-enhanced spectrofluorimetric method for determination of cholesterol-reducing drug ezetimibe in dosage forms.
Alarfaj NA; Aly FA
J Fluoresc; 2012 Jan; 22(1):9-15. PubMed ID: 21858740
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of highly Sensitive Stability Indicating Spectrofluorimetric Method for Determination of Amlodipine in Pharmaceutical Preparations and Human Plasma.
Mohamed AI; Omar MA; Hammad MA; Mohamed AA
J Fluoresc; 2016 Nov; 26(6):2141-2149. PubMed ID: 27566613
[TBL] [Abstract][Full Text] [Related]
13. Stability-indicating micelle-enhanced spectrofluorimetric method for determination of loratadine and desloratadine in dosage forms.
Walash MI; Belal F; El-Enany N; Eid M; El-Shaheny RN
Luminescence; 2011; 26(6):670-9. PubMed ID: 21491578
[TBL] [Abstract][Full Text] [Related]
14. Micelle-enhanced spectrofluorimetric determination of amlexanox in bioadhesive buccal tablets: application to content uniformity testing.
Walash MI; Belal F; Tolba MM; Halawa MI
Luminescence; 2015 Sep; 30(6):823-9. PubMed ID: 25611457
[TBL] [Abstract][Full Text] [Related]
15. Determination of the anti-viral drug Ribavirin in dosage forms via micelle-enhanced spectrofluorimetric method.
Alarfaj NA; El-Tohamy MF
Luminescence; 2013; 28(2):190-4. PubMed ID: 22473851
[TBL] [Abstract][Full Text] [Related]
16. Micelle-enhanced spectrofluorimetric method for determination of cyproheptadine hydrochloride in tablets: application to in-vitro drug release and content uniformity test.
Belal F; El-Din MK; Tolba MM; Elmansi H
J Fluoresc; 2014 Jan; 24(1):85-91. PubMed ID: 23900846
[TBL] [Abstract][Full Text] [Related]
17. Spectrofluorimetric determination of certain adrenergic agonist drugs in their pure forms and pharmaceutical formulations: Content uniformity test application.
Badr El-Din KM; Attia TZ
Luminescence; 2017 Aug; 32(5):706-712. PubMed ID: 27900836
[TBL] [Abstract][Full Text] [Related]
18. Stability-indicating micellar enhanced spectro-fluorometric determination of Daclatasvir in its tablet and spiked human plasma.
Sultan MA; Abou El-Alamin MM; Wark AW; Azab MM
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Mar; 211():52-58. PubMed ID: 30503988
[TBL] [Abstract][Full Text] [Related]
19. Micelle and inclusion complex enhanced spectrofluorimetric methods for determination of Retigabine: Application in pharmaceutical and biological analysis.
Mostafa AM; Rageh AH; Ali MFB; Mohamed FA
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Jan; 207():251-261. PubMed ID: 30248612
[TBL] [Abstract][Full Text] [Related]
20. Spectrofluorometric determination of fluvoxamine in dosage forms, spiked plasma, and real human plasma by derivatization with fluorescamine.
El-Enany N
J AOAC Int; 2007; 90(2):376-83. PubMed ID: 17474508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
